Analyst Ratings for MapLight Therapeutics (MPLT)
MPLT Rating Summary
MPLT Price Target Summary
- Highest: $48.00 (UBS)
- Lowest: $30.00 (Leerink)
- Average: $36.88
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$36.88 (+27.9%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/26/2026 | UBS | Ashwani Verma | New Coverage | Buy (N/A) |
48.00 (N/A) |
28.75 (28.82) |
0.24% | Details |
| 5/21/2026 | Craig-Hallum | Adam Vogel | New Coverage | Buy (N/A) |
43.00 (N/A) |
27.81 (28.82) |
3.63% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
